China (Mainland)
High Purity GW0742 Cas 317318-84-6 CAS NO.317318-84-6
- FOB Price: USD: 0.80-1.00 /Metric Ton Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,T/T,
- Available Specifications:
99%(1-5)Metric Ton99%(6-10)Metric Ton
- Product Details
Keywords
- 317318-84-6
- GW-0742
- GW0742X
Quick Details
- ProName: High Purity GW0742 Cas 317318-84-6
- CasNo: 317318-84-6
- Molecular Formula: C21H17F4NO3S2
- Appearance: white crystalline powder
- Application: GW0742 has been proposed as a potentia...
- DeliveryTime: 7 days for OEM, 3 days for ready goods
- PackAge: Ordinary packing or according to custo...
- Port: All ports in China
- ProductionCapacity: 10 Kilogram/Month
- Purity: 99%
- Storage: Cool & dry place
- Transportation: Air transportation and surface transpo...
- LimitNum: 1 Kilogram
- Moisture Content: 1
- Impurity: 1
Superiority
GW0742 is a selective PPARδ agonist (EC50 = 1.1 nM) that exhibits 1,000-fold selectivity over the other human PPAR subtypes. GW 0742 exhibits time-dependent neuroprotection in low KCl-induced apoptosis in cerebellar granule neuronal cultures. Despite the neuroprotective properties observed, prolonged (48h) incubation with GW 0742 produced significant inherent toxicity. This cell death was determined to be apoptotic as identified with the TUNEL assay.
GW0742 activates AMP-activated protein kinase and stimulates glucose uptake in skeletal muscle tissue , and GW 501516 has been demonstrated to reverse metabolic abnormalities in obese men with pre-diabetic metabolic syndrome , most likely by stimulating fatty acid oxidation .
Details
|
|
C21H17F4NO3S2 |
|---|---|
|
|
317318-84-6
|
GW0742 is a selective PPARδ agonist (EC50 = 1.1 nM) that exhibits 1,000-fold selectivity over the other human PPAR subtypes. GW 0742 exhibits time-dependent neuroprotection in low KCl-induced apoptosis in cerebellar granule neuronal cultures. Despite the neuroprotective properties observed, prolonged (48h) incubation with GW 0742 produced significant inherent toxicity. This cell death was determined to be apoptotic as identified with the TUNEL assay.
GW0742 activates AMP-activated protein kinase and stimulates glucose uptake in skeletal muscle tissue , and GW 501516 has been demonstrated to reverse metabolic abnormalities in obese men with pre-diabetic metabolic syndrome , most likely by stimulating fatty acid oxidation .
GW0742 has been proposed as a potential treatment for obesity and related conditions , especially when used in conjunction with a synergistic compound AICAR , as the combination has been shown to significantly increase exercise endurance in human.
Whatsapp； +86 199 1301 0653 、 +86 188 3295 9082
E-mail : bs1046490047(at)hbbocao.com